Follow

CombiGene AB

Nasdaq First North GM Stockholm (Sweden)

CombiGene is a gene therapy explorer based in Sweden. The Company is engaged in developing new methods for the treatment of neurological diseases and for epileptic patients who cannot be helped by available medical treatments at present.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
COMBI
SE0016101935
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Active
Currency
SEK
First trading date
25 May 2015
Exercise
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Exercise
Sign in to buy
Set-off issue
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Directed issue
Sign in to buy
Exercise
Sign in to buy
Directed issue
Sign in to buy
Exercise
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
COMBI
SE0006504593
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Archived
Currency
SEK
First trading date
25 May 2015
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Rights issue
Sign in to buy
Market move
Sign in to buy
Set-off issue
Sign in to buy
Rights issue
Sign in to buy
Private placement
Sign in to buy
Directed issue
Sign in to buy
Directed issue
Sign in to buy
Rights issue
Sign in to buy
Type
Ticker
ISIN
Market
SHARE
COMBI
SE0016101935
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in CombiGene AB with ticker COMBI
Status
Active
Currency
SEK
Type
Ticker
ISIN
Market
OPTION
COMBI TO 1
SE0006510178
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 1
Status
Archived
Currency
SEK
Trading period
25 May 2015 - 15 Feb 2016
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for SEK 7.50.
Update (12.10.2015): Today marks the start of the first subscription period for TO 1.
Update (08.02.2016): Today marks the start of the last subscription period for TO 1.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
COMBI TO 2
SE0011616408
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 2
Status
Archived
Currency
SEK
Trading period
19 Dec 2018 - 27 Sep 2019
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for price correspondning to seventy (70) percent volume-weighted average trading price at Nasdaq First North Sweden marketplace from the period of August 15, 2019 until August 28, 2019 but at least SEK 2.0 per share up to the maximum of SEK 2.50 per share. The subscription period with the support of warrants will take place from September 1, 2019 until September 30, 2019.
Update (24.10.2018): Information about CombiGene's warrant.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
COMBI TO 3
SE0014111308
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 3
Status
Archived
Currency
SEK
Trading period
20 May 2020 - 27 Aug 2020
Terms
One (1) warrant of series TO 3 entitles the holder to subscribe for one (1) new share in the Company for the subscription price which will be determined with the guidance of ten (10) trading days volume-weighted average price (VWAP) before the redemption with a discount of thirty (30) percent, but at least SEK 0.4 per share and a maximum of SEK 0.6 per share.
Update (17.08.2020): Exercise period for warrants of series TO3 in CombiGene begins today.
Exercise
Sign in to buy
Type
Ticker
ISIN
Market
OPTION
COMBI TO 4
SE0014111316
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in CombiGene AB with ticker COMBI TO 4
Status
Archived
Currency
SEK
Trading period
20 May 2020 - 26 Nov 2020
Terms
One (1) warrant of series TO 4 entitles the holder to subscribe for one (1) new share in the Company for the subscription price which will be determined with the guidance of ten (10) trading days volume-weighted average price (VWAP) before the redemption with a discount of thirty (30) percent, but at least SEK 0.5 per share and a maximum of SEK 0.7 per share.
Update (16.11.2020): Exercise period for warrants of series TO4 and TO5 in CombiGene AB begins today.
Exercise
Sign in to buy
People
Peter Ekolind
CEO
Jonas Ekblom
Chairman of the board
Per Lundin
Board member
Peter Nilsson
Board member
Jan Nilsson
Board member
Gunilla Lundmark
Board member
Bert Junno
Board member
Company Details
Sector
HEALTH CARE

Address
Scheelevägen 2
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556403-3818
LEI code
213800CITFPHX4TL8G93
First trade date
25 May 2015
Registration date
03 Oct 1990
Short name
COMBI

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More